205 results on '"Mirshahi, Faridoddin"'
Search Results
2. The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma
3. Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis
4. Loss of TIM4-Dependent Efferocytosis in Kupffer Cells Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
5. Decoding hepatocyte transcriptional responses in murine non-alcoholic steatohepatitis using single-nucleus RNA-sequencing
6. A shift in the hepatic immunological pattern from predominant adaptive immunity to innate immunity compromises tissue-specific immunity and leads to HCC
7. Restoration of CD4 +T helper cells without modulating the hepatic inflammatory pattern is not sufficient to prevent HCC
8. The multifaceted role of natriuretic peptides in metabolic syndrome
9. Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
10. Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease
11. Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
12. Restoration of CD4+ T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
13. sj-docx-1-pat-10.1177_2632010X231162317 – Supplemental material for Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
14. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
15. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
16. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
17. Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
18. Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
19. Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
20. Withaferin A Acts as a Novel Ligand and Regulator of Liver X Receptor-α in Hepatocellular Carcinoma
21. Restoration of CD4 + T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC.
22. Identification of a metabolic, transcriptomic and molecular signature of PNPLA3-mediated acceleration of steatohepatitis
23. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
24. WED-422 - Decoding hepatocyte transcriptional responses in murine non-alcoholic steatohepatitis using single-nucleus RNA-sequencing
25. Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
26. Distinct Hepatic Immunological Patterns are Associated With the Progression or Inhibition of Hepatocellular Carcinoma
27. Emerging roles of AATF: Checkpoint signaling and beyond
28. Physiologic concentrations of leptin increase collagen production by non-immortalized human hepatic stellate cells
29. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
30. The development and severity of alcoholic hepatitis is associated with decreased intestinal microbiome-derived secondary bile acid isoursodeoxycholic acid
31. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
32. Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity
33. Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer
34. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
35. A lipidomic analysis of nonalcoholic fatty liver disease
36. Emerging roles of AATF: Checkpoint signaling and beyond.
37. 318 – Haptoglobin 2 Allele is Associated with Increased Risk and Severity of Alcoholic Hepatitis
38. THU-295-Non-alcoholic fatty liver disease is associated with QTc lengthening in the general population
39. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
40. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
41. Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer.
42. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
43. Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis
44. Systemic and portal hemodynamic effects of anandamide
45. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
46. Suppression of IGF binding protein‐3 by palmitate promotes hepatic inflammatory responses
47. Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
48. Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese
49. Sa1672 Manassatin, a Plant Based Compound Ameliorates AMPK and Suppresses ERK1/2 Pathways in Human Hepatocytes - A Novel Therapeutic Target for Nonalcoholic Fatty Liver Disease
50. Mo1544 Nonalcoholic Steatohepatitis Is Associated With a State of Betaine-Insufficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.